Cited by — A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.
No admitted local citation edges point to this work yet.
